Piras et al. performed immunohistochemical (IHC) analysis of primary cutaneous melanoma specimens, and demonstrated that CD8+ lymphocytes at the base of the tumor mass exhibited a statistically positive, significant correlation with survival [8]. This evidence concerns the gene CD8A and cutaneous melanoma.